We are live on ! Find out more
VPHM

VIROPHARMA INC
VPHM

Delisted

VPHM was delisted on the 23rd of January, 2014.

Back to rankings

0 hedge funds and large institutions have $0 invested in VIROPHARMA INC in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 169 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 172 → 0 (-172)

100% less funds holding in top 10

Funds holding in top 10: 11 → 0 (-11)

100% less capital invested

Capital invested by funds: $3.29B → $0 (-$3.29B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 169

Holders
–
Holders Change
-172
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
169
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$477M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$205M
3
BFA
BlackRock Fund Advisors
California
-$188M
4
OAM
Oxford Asset Management
United Kingdom
-$153M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$142M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
126
First Trust Advisors
Illinois
– -$567K -11,370 Closed
AAM
127
Advisors Asset Management
Colorado
– -$548K -10,983 Closed
MSA
128
Mason Street Advisors
Wisconsin
– -$507K -10,162 Closed
FFH
129
Fairfax Financial Holdings
Ontario, Canada
– -$498K -10,000 Closed
GPCM
130
Granite Point Capital Management
Massachusetts
– -$499K -10,000 Closed
State of Wisconsin Investment Board
131
State of Wisconsin Investment Board
Wisconsin
– -$494K -9,900 Closed
HCM
132
Highbridge Capital Management
New York
– -$442K -8,873 Closed
KBC Group
133
KBC Group
Belgium
– -$425K -8,523 Closed
Los Angeles Capital Management
134
Los Angeles Capital Management
California
– -$388K -7,791 Closed
ProShare Advisors
135
ProShare Advisors
Maryland
– -$381K -7,649 Closed
WFM
136
Wilmington Funds Management
Delaware
– -$360K -7,224 Closed
AB
137
Amalgamated Bank
New York
– -$338K -6,771 Closed
AA
138
Ancora Advisors
Ohio
– -$334K -6,700 Closed
AIP
139
Ameritas Investment Partners
Nebraska
– -$287K -5,753 Closed
LOM
140
Loeb Offshore Management
New York
– -$283K -5,676 Closed
SB
141
Suntrust Banks
Georgia
– -$278K -5,594 Closed
RFC
142
Russell Frank Company
Washington
– -$266K -5,327 Closed
DTL
143
Dynamic Technology Lab
Singapore
– -$264K -5,303 Closed
HIMCH
144
Hartford Investment Management Co (HIMCO)
Connecticut
– -$231K -4,634 Closed
BF
145
BOK Financial
Oklahoma
– -$231K -4,630 Closed
Millennium Management
146
Millennium Management
New York
– -$205K -4,106 Closed
Canada Life
147
Canada Life
Manitoba, Canada
– -$186K -3,705 Closed
OA
148
OFI Advisors
Pennsylvania
– -$176K -3,523 Closed
PAM
149
Paradigm Asset Management
New York
– -$162K -3,250 Closed
SG Americas Securities
150
SG Americas Securities
New York
– -$157K -3,148 Closed
3 4 5
6
7

VPHM Hedge Fund Activity: Q1 2014 in Review

0 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in VIROPHARMA INC (VPHM) for Q1 2014, worth a combined $0 — down 100% from $3.29B a quarter earlier.

Sellers outnumbered buyers: 169 funds closed out of VPHM and 0 opened new positions — a net loss of 169 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $477M sold.

  • 0 institutional investors held VIROPHARMA INC (VPHM) as of Q1 2014, down from 172 in Q4 2013.
  • Funds reported $0 of VIROPHARMA INC stock for Q1 2014, down 100% quarter-over-quarter.
  • 0 funds opened new VIROPHARMA INC positions in Q1 2014 and 169 closed out, a net change of -169 holders.
  • The largest VIROPHARMA INC seller in Q1 2014 was Fidelity Investments, an estimated $477M sold.

Based on aggregated 13F filings for Q1 2014.